All About Gamma Globulin: What Nurses Should Know
What Is Gamma Globulin?
In the context of treatment, gamma globulin commonly refers to immunoglobulin therapy. These medications contain antibodies, primarily immunoglobulin G (IgG), obtained from donated human plasma.
For patients with certain antibody deficiencies, immunoglobulin replacement provides antibodies that help protect against infections. It does not correct the underlying inability to produce effective antibodies, so ongoing treatment may be necessary. Examples of conditions treated include common variable immunodeficiency and X-linked agammaglobulinemia. Immune Deficiency Foundation
How Is It Administered?
Immunoglobulin replacement can be delivered intravenously (IVIG), directly into the bloodstream, or subcutaneously (SCIG), into the tissue beneath the skin. The product, route, dose, and schedule are tailored to the patient’s medical needs and treatment preferences. Some patients can administer SCIG at home after appropriate training. Immune Deficiency Foundation
For nurses, a key principle is to follow the prescribed product’s instructions. Preparation requirements and infusion rates vary, making the current prescribing information an essential reference. For example, GAMMAGARD LIQUID provides separate instructions for intravenous and subcutaneous administration. GAMMAGARD LIQUID prescribing information
Recognizing Adverse Reactions
Knowing the potential reactions helps nurses recognize changes promptly. Reported reactions include headache, fatigue, nausea, fever, and chills. Subcutaneous administration may also cause local infusion-site reactions.
Serious risks include severe allergic reactions, blood clots, and kidney dysfunction. Other potential complications include hemolysis and aseptic meningitis. Risk assessment and monitoring should follow the specific product’s labeling and the patient’s care plan.
Making Patient Education Meaningful
Patient education should help people understand the purpose of treatment, their schedule, and how to communicate concerns. Encourage patients to track reactions during or after infusions and share them with their healthcare team. Consistent treatment and ongoing review help clinicians assess whether the regimen is meeting the patient’s needs.
Useful teaching conversations can explore what the patient understands, what feels difficult, and which questions remain unanswered. Asking patients to explain the plan in their own words can help identify areas that need more discussion.
Build Your Knowledge With Continuing Education
Pedagogy’s All About Gamma Globulin course offers a focused opportunity to review this therapy. Its curriculum addresses intravenous and subcutaneous administration, common and uncommon adverse events, anaphylaxis, patient education, assessment, and documentation.
The course page lists 1.5 contact hours and a $18 price. Visit All About Gamma Globulin for course details and enrollment information.
